03-16524. Research and Development Office; Government Owned Invention Available for Licensing

AGENCY:

Research and Development Office, DVA.

ACTION:

Notice of government owned invention available for licensing.

SUMMARY:

The invention listed below is owned by the U.S. Government as represented by the Department of Veterans Affairs, and is available for licensing in accordance with 35 U.S.C. 207 and 37 CFR part 404 to achieve expeditious commercialization of results of federally funded research and development. Foreign patents are filed on selected inventions to extend market coverage for U.S. companies and may also be available for licensing.

FOR FURTHER INFORMATION CONTACT:

Technical and licensing information on the invention may be obtained by writing to: Mindy Aisen, MD, Department of Veterans Affairs, Director Technology Transfer Program, Research and Development Office, 810 Vermont Avenue NW., Washington, DC 20420; fax: [phone]; email at [e-mail]. Any request for information should include the Number and Title for the relevant invention as indicated below. Issued patents may be obtained from the Commissioner of Patents, U.S. Patent and Trademark Office, Washington, DC 20231.

SUPPLEMENTARY INFORMATION:

The invention available for licensing is: 10/360,720 “Method of Inhibiting Angiogenesis and Neuroblastoma Growth with α and β Isoforms of Neu Differentiation Factor (NDF α and NDF β).

Dated: June 20, 2003.

Anthony J. Principi,

Secretary, Department of Veterans Affairs.